BRAF V600E Mutation Is Associated with mTOR Signaling Activation in Glioneuronal Tumors

BRAF V600E mutations have been recently reported in glioneuronal tumors (GNTs). To evaluate the expression of the BRAF V600E mutated protein and its association with activation of the mammalian target of rapamycin (mTOR) pathway, immunophenotype and clinical characteristics in GNTs, we investigated...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Brain Pathol
Asıl Yazarlar: Prabowo, Avanita S., Iyer, Anand M., Veersema, Tim J., Anink, Jasper J., Schouten‐van Meeteren, Antoinette Y. N., Spliet, Wim G. M., van Rijen, Pieter C., Ferrier, Cyrille H., Capper, David, Thom, Maria, Aronica, Eleonora
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2013
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029322/
https://ncbi.nlm.nih.gov/pubmed/23941441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bpa.12081
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller